BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

495 related articles for article (PubMed ID: 24186066)

  • 21. Regulation of receptor tyrosine kinase signaling by endocytic trafficking.
    Wiley HS; Burke PM
    Traffic; 2001 Jan; 2(1):12-8. PubMed ID: 11208164
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Regulation of receptor tyrosine kinase ligand processing.
    Adrain C; Freeman M
    Cold Spring Harb Perspect Biol; 2014 Jan; 6(1):. PubMed ID: 24384567
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Endocytosis and signaling.
    Platta HW; Stenmark H
    Curr Opin Cell Biol; 2011 Aug; 23(4):393-403. PubMed ID: 21474295
    [TBL] [Abstract][Full Text] [Related]  

  • 24. GGA3 functions as a switch to promote Met receptor recycling, essential for sustained ERK and cell migration.
    Parachoniak CA; Luo Y; Abella JV; Keen JH; Park M
    Dev Cell; 2011 Jun; 20(6):751-63. PubMed ID: 21664574
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nbr1 is a novel inhibitor of ligand-mediated receptor tyrosine kinase degradation.
    Mardakheh FK; Auciello G; Dafforn TR; Rappoport JZ; Heath JK
    Mol Cell Biol; 2010 Dec; 30(24):5672-85. PubMed ID: 20937771
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Spatial restriction of receptor tyrosine kinase activity through a polarized endocytic cycle controls border cell migration.
    Assaker G; Ramel D; Wculek SK; González-Gaitán M; Emery G
    Proc Natl Acad Sci U S A; 2010 Dec; 107(52):22558-63. PubMed ID: 21149700
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Controlling receptor downregulation by ubiquitination and deubiquitination.
    Komada M
    Curr Drug Discov Technol; 2008 Mar; 5(1):78-84. PubMed ID: 18537571
    [TBL] [Abstract][Full Text] [Related]  

  • 28. All Good Things Must End: Termination of Receptor Tyrosine Kinase Signal.
    Margiotta A
    Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34198477
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Conserved roles for receptor tyrosine kinase extracellular regions in regulating receptor and pathway activity.
    Gonzalez-Magaldi M; McCabe JM; Cartwright HN; Sun N; Leahy DJ
    Biochem J; 2020 Nov; 477(21):4207-4220. PubMed ID: 33043983
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evidence for efficient phosphorylation of EGFR and rapid endocytosis of phosphorylated EGFR via the early/late endocytic pathway in a gefitinib-sensitive non-small cell lung cancer cell line.
    Nishimura Y; Yoshioka K; Bereczky B; Itoh K
    Mol Cancer; 2008 May; 7():42. PubMed ID: 18492291
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Proteolytic cleavage, trafficking, and functions of nuclear receptor tyrosine kinases.
    Chen MK; Hung MC
    FEBS J; 2015 Oct; 282(19):3693-721. PubMed ID: 26096795
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Advances in Membrane Trafficking and Endosomal Signaling of G Protein-Coupled Receptors.
    Hanyaloglu AC
    Int Rev Cell Mol Biol; 2018; 339():93-131. PubMed ID: 29776606
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interplay of autophagy, receptor tyrosine kinase signalling and endocytic trafficking.
    Fraser J; Cabodevilla AG; Simpson J; Gammoh N
    Essays Biochem; 2017 Dec; 61(6):597-607. PubMed ID: 29233871
    [TBL] [Abstract][Full Text] [Related]  

  • 34. UBE4B protein couples ubiquitination and sorting machineries to enable epidermal growth factor receptor (EGFR) degradation.
    Sirisaengtaksin N; Gireud M; Yan Q; Kubota Y; Meza D; Waymire JC; Zage PE; Bean AJ
    J Biol Chem; 2014 Jan; 289(5):3026-39. PubMed ID: 24344129
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Suppressors of T-cell receptor signaling Sts-1 and Sts-2 bind to Cbl and inhibit endocytosis of receptor tyrosine kinases.
    Kowanetz K; Crosetto N; Haglund K; Schmidt MHH; Heldin CH; Dikic I
    J Biol Chem; 2004 Jul; 279(31):32786-95. PubMed ID: 15159412
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Postendocytic trafficking of epidermal growth factor-receptor complexes is mediated through saturable and specific endosomal interactions.
    French AR; Sudlow GP; Wiley HS; Lauffenburger DA
    J Biol Chem; 1994 Jun; 269(22):15749-55. PubMed ID: 8195228
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The interface of receptor trafficking and signalling.
    Clague MJ; Urbé S
    J Cell Sci; 2001 Sep; 114(Pt 17):3075-81. PubMed ID: 11590234
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Distinct monoubiquitin signals in receptor endocytosis.
    Haglund K; Di Fiore PP; Dikic I
    Trends Biochem Sci; 2003 Nov; 28(11):598-603. PubMed ID: 14607090
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Defective downregulation of receptor tyrosine kinases in cancer.
    Bache KG; Slagsvold T; Stenmark H
    EMBO J; 2004 Jul; 23(14):2707-12. PubMed ID: 15229652
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of N-linked glycosylation disrupts receptor tyrosine kinase signaling in tumor cells.
    Contessa JN; Bhojani MS; Freeze HH; Rehemtulla A; Lawrence TS
    Cancer Res; 2008 May; 68(10):3803-9. PubMed ID: 18483264
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.